Grant: Discovery Grants Program - Individual
Université de Montréal
$47,000.00
The role and mechanisms of EPHB4 in controlling heart rhythm
FY 2024-25
Summary
This project does not involve indigenous communities or individuals.
The applicant is a pioneer in erythropoietin-producing hepatocyte kinases (EPHs). His studies in this field represent a major, long-term program since 1995 (funded by NSERC and other agencies) with more than 27 papers published (1-27). The PI is an internationally recognized leader in this field. He was the chair of the organizing committee of the successful 3rd Congress of the EPH/Ephrin System held in Montreal on June 1 and 2, 2022, the largest gathering of 75 prominent internal EPH researchers, mostly PIs. He is also an organizer for the 4th Congress of the EPH/Ephrin System to be held in Parma, Italy, on May 30-31, 2024.
THE OBJECTIVE OF HIS LONG-TERM EPH RESEARCH PROGRAM is to discover novel functions and underlying mechanisms of different EPHs and their ligand ephrins (EFNs) in the immune and cardiovascular systems. Three to five Ph.D. students will be trained in the next ten years in this program.
THE SHORT-TERM OBJECTIVE OF THE CURRENT PROPOSAL is to elucidate the signaling pathways from cell surface EPHB4 to mRNA transcription of HCN4 in the pacing cells, pacing cells being the controller of the heart rate and HCN4 being a critical molecule in determining the pacing cell rhythm. Two Ph.D. students will be trained in the next five years.
RATIONALES EPHs are the largest family of protein receptor tyrosine kinases. We had an unexpected novel finding that conditional EPHB4 gene knockout (KO) in female mice resulted in lower heart rates. The female but not male KO mice had reduced expression of HCN4 in the sinus atrial node of the heart. Pacing cells developed from female EPHB4 KO embryonic stem cells showed decreased HCN4 expression and slower pacing rhythm compared to their wild-type (WT) counterparts. How the cell surface EPHB4 on the pacing cells or their progenitors controls HCN4 transcription is not known.
THE MAJOR HYPOTHESIS is that EPHB4 kinase affects multiple signaling pathways from the cell surface to the two major enhancers in the first exon of Hcn4 in a sex- or sex hormone-dependent way and controls HCN4 expression in the developing pacing cells. As such, EPHB4 plays a previously unknown role in heart rhythm control.
SPECIFIC AIMS AND EXPERIMENTAL DESIGNS
I. To decipher whether it is sex or sex hormones that act in concert with EPHB4 to regulate HCN4 expression and heart rhythm
II. A candidate approach to investigate the signaling pathways from EPHB4 to HCN4 transcription
III. To use stable isotope labeling by amino acid in cell culture to identify direct substrates of EPHB4 and connect EPHB4 to transcription factors for the two enhancers, i.e., AP-1 and MEF2, that regulate HCN4 expression.
SIGNIFICANCE
Our study will enhance our knowledge of the function and action mechanisms of EPHB4 kinase in regulating HCN4 transcription and pacing cell development. During the tenure of this project, we will train several high-quality personnel.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2024-05686
Name nom
Wu, Jiangping
Department département
Medicine
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2024
Award amount
47000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
The role and mechanisms of EPHB4 in controlling heart rhythm
Keywords
ephb4 kinase; hcn4; kinase substrate profiling; cell signaling; gene knockout mice; embryonic stem cells; transcription factors
Application summary
This project does not involve indigenous communities or individuals.
The applicant is a pioneer in erythropoietin-producing hepatocyte kinases (EPHs). His studies in this field represent a major, long-term program since 1995 (funded by NSERC and other agencies) with more than 27 papers published (1-27). The PI is an internationally recognized leader in this field. He was the chair of the organizing committee of the successful 3rd Congress of the EPH/Ephrin System held in Montreal on June 1 and 2, 2022, the largest gathering of 75 prominent internal EPH researchers, mostly PIs. He is also an organizer for the 4th Congress of the EPH/Ephrin System to be held in Parma, Italy, on May 30-31, 2024.
THE OBJECTIVE OF HIS LONG-TERM EPH RESEARCH PROGRAM is to discover novel functions and underlying mechanisms of different EPHs and their ligand ephrins (EFNs) in the immune and cardiovascular systems. Three to five Ph.D. students will be trained in the next ten years in this program.
THE SHORT-TERM OBJECTIVE OF THE CURRENT PROPOSAL is to elucidate the signaling pathways from cell surface EPHB4 to mRNA transcription of HCN4 in the pacing cells, pacing cells being the controller of the heart rate and HCN4 being a critical molecule in determining the pacing cell rhythm. Two Ph.D. students will be trained in the next five years.
RATIONALES EPHs are the largest family of protein receptor tyrosine kinases. We had an unexpected novel finding that conditional EPHB4 gene knockout (KO) in female mice resulted in lower heart rates. The female but not male KO mice had reduced expression of HCN4 in the sinus atrial node of the heart. Pacing cells developed from female EPHB4 KO embryonic stem cells showed decreased HCN4 expression and slower pacing rhythm compared to their wild-type (WT) counterparts. How the cell surface EPHB4 on the pacing cells or their progenitors controls HCN4 transcription is not known.
THE MAJOR HYPOTHESIS is that EPHB4 kinase affects multiple signaling pathways from the cell surface to the two major enhancers in the first exon of Hcn4 in a sex- or sex hormone-dependent way and controls HCN4 expression in the developing pacing cells. As such, EPHB4 plays a previously unknown role in heart rhythm control.
SPECIFIC AIMS AND EXPERIMENTAL DESIGNS
I. To decipher whether it is sex or sex hormones that act in concert with EPHB4 to regulate HCN4 expression and heart rhythm
II. A candidate approach to investigate the signaling pathways from EPHB4 to HCN4 transcription
III. To use stable isotope labeling by amino acid in cell culture to identify direct substrates of EPHB4 and connect EPHB4 to transcription factors for the two enhancers, i.e., AP-1 and MEF2, that regulate HCN4 expression.
SIGNIFICANCE
Our study will enhance our knowledge of the function and action mechanisms of EPHB4 kinase in regulating HCN4 transcription and pacing cell development. During the tenure of this project, we will train several high-quality personnel.